Discover 1,948 paid clinical trials in Irving, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,948
A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)
for
Diffuse Large B-Cell Lymphoma
Location: Dallas TX, The Woodlands TX, Houston TX, Alexandria LA,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06717347
Phase 3, Recruiting
Mocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Allo-HCT
for
Adult Acute Myeloid Leukemia
Location: Dallas TX, Westwood KS, Iowa City IA, Atlanta GA,
Sponsor: Priothera SAS
Sex: All
Age: 18 - 70+
Code: NCT05429632
Phase 3, Recruiting
Treatment Study Comparing Aripiprazole Once Monthly With Standard of Care Medication in Outpatients With Schizophrenia
for
Schizophrenia
Location: Dallas TX
Sponsor: Matt Byerly
Sex: All
Age: 18 - 60
Code: NCT02282085
Recruiting
Nerve Decompression for Ulcer Recurrence Avoidance (DURA)
for
Diabetic Ulcer of Plantar Aspect of Left Foot,
Location: Denton TX, Houston TX, Jasper IN, Tucson AZ,
Sponsor: Association of Extremity Nerve Surgeons
Sex: All
Age: 18 - 70+
Code: NCT01762085
Recruiting
Efficacy of LoDoCo in Improving Exercise Capacity Among Patients With HFpEF and Inflammation
for
Heart Failure, Inflammation
Location: Dallas TX
Sponsor: University of Texas Southwestern Medical Center
Sex: All
Age: 50+
Code: NCT06130059
Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
for
Atrial Fibrillation (AF)
Location: Dallas TX, Allen TX, Wylie TX, McKinney TX,
Sponsor: Anthos Therapeutics, Inc.
Sex: All
Age: 65+
Code: NCT05712200
Phase 3, Recruiting
A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors
Location: Dallas TX, Little Rock AR, Baton Rouge LA,
Sponsor: Genzyme, a Sanofi Company
Sex: All
Age: 0+
Code: NCT00196742
Recruiting
A Study to Investigate the Efficacy and Safety of Anifrolumab Administered as Subcutaneous Injection and Added to Standard of Care Compared With Placebo Added to Standard of Care in Adult Participants With Idiopathic Inflammatory Myopathies (Polymyositis and Dermatomyositis)
for
Polymyositis, Dermatomyositis
Location: Colleyville TX, North Richland Hills TX, Allen TX,
Sponsor: AstraZeneca
Sex: All
Age: 18 - 70+
Code: NCT06455449
Phase 3, Recruiting
Safety and Effectiveness of Minimally Invasive Micro Sclerostomy (MIMS®) to Reduce Intraocular Pressure in Open-Angle Glaucoma Which is Not Controlled Despite Polypharmacy
for
Primary Open Angle Glaucoma, Open Angle Glaucoma
Location: Dallas TX
Sponsor: Sanoculis Ltd
Sex: All
Age: 40 - 70+
Code: NCT06313749
Recruiting
Pembrolizumab Plus CA-4948 for the Treatment of Patients With Progressive Metastatic Urothelial Cancer Despite Prior Immunotherapy
for
Metastatic Urothelial Carcinoma,
Location: Dallas TX, Atlanta GA, Miami FL, La Jolla CA, Irvine CA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06439836
Phase 1, Recruiting
A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT